|
|
 |
|
Viewing report
|
|
|
|
Nephros, Inc. (NEPH) - Product Pipeline Analysis
GlobalData, Aug 2011, Pages: 30
Nephros, Inc. (NEPH) - Product Pipeline Analysis
Summary
Nephros, Inc. (Nephros) is US-based medical device company that is engaged in developing and marketing filtration products for therapeutic applications, infection control, and water purification. Nephros principally develops hemodiafiltration (HDF) products and technologies for treating patients with end-stage renal disease. The company has three products in various stages of development in the HDF modality to deliver improved therapy to ESRD patients i.e., OLpur MDHDF filter series - OLpur H2H, OLpur NS2000 system and OLpur HD 190 high-flux dialyzer cartridge. Nephros offers products to healthcare providers such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups. The company sells products to France, Germany, Ireland, Italy, Cyprus, Denmark, Greece, the Netherlands, Norway, Portugal, Spain, Sweden and Switzerland and the UK. It is headquartered in River Edge, the US.
This report is a source for data, analysis and actionable intelligence on the Nephros, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Customers who bought this item also bought
B. Braun Melsungen AG - Product Pipeline Analysis
Biosense Webster, Inc. - Product Pipeline Analysis
Alliqua, Inc. (HPLF) - Product Pipeline Analysis
XCounter AB (XCT) - Product Pipeline Analysis
Biosign Technologies Inc. (BIO) - Product Pipeline Analysis
Xcorporeal, Inc. (XCRP) - Product Pipeline Analysis
Biosite Incorporated - Product Pipeline Analysis
Gambro AB - Product Pipeline Analysis
DURECT Corporation (DRRX) - Product Pipeline Analysis
Alphatec Holdings, Inc. (ATEC) - Product Pipeline Analysis
|
|
|
|
